Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
ANDA219975 + ANDA220011
Phase 3 small_molecule active
Quick answer
Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes for Type 2 Diabetes is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Type 2 Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active